CSL became the only stock in Australia to be trading above $100 on Tuesday 4th August. CSL was previously known as Commonwealth Serum Laboratories and started operating as a government vaccine manufacturer at the Melbourne Hospital in 1916. CSL was privatised and listed on the ASX on 4th June 1994.
Quest has now established a ten year record in funds management for institutional and high net worth portfolios. The Morningstar survey indicates that the Quest composite return for fiscal 2015 was 9.4% (pre fees) and ranked at number 14 of the 82 fund managers in the survey.